DermaDetect
AI-driven Digital Diagnostics for Skin Disorders
Company Overview
Snapshot
Founded in November 2016 by Eugene Dicker, Gennadi Schechtmann, Prof. Arieh Ingber, and Dr. Guy Steuer, DermaDetect operates with 1–10 employees. The company has raised a total of $4.35M across 6 funding rounds from 6 investors.
Business overview
DermaDetect provides an AI-driven software platform for the remote diagnosis and treatment of skin disorders. Its core technology leverages intelligent software to integrate seamlessly with existing systems, offering 24/7 accessibility and a pay-per-usage model. The company serves various dermatological disciplines and has expanded its product line to include DermaAssess and DermaManage. DermaDetect's FDA/CE-cleared platform is currently being rolled out across the Maccabi Health Services network in Israel, serving over 2.5 million patients and enhancing clinical workflows for healthcare providers in the Health Tech & Life Sciences sector.
Strategic signal
DermaDetect's strategic rollout of its automated skin diagnosis application across the Maccabi Health Services network in Israel, serving over 2.5 million patients, signals strong market adoption and validation of its AI-driven diagnostic capabilities. This expansion demonstrates the company's ability to integrate its technology into large healthcare systems, indicating significant potential for scaling its impact and revenue within the digital health and medical diagnostics market.
Log in to access full profile ›Company Intelligence Q&A
- When was DermaDetect founded and by whom?
- DermaDetect was founded in November 2016 by Eugene Dicker, Gennadi Schechtmann, Prof. Arieh Ingber, and Dr. Guy Steuer.
- What is DermaDetect's primary product offering?
- DermaDetect offers an AI-driven software platform for the remote diagnosis and treatment of skin disorders, including products like DermaDetect, DermaAssess, and DermaManage.
- Which organization is implementing DermaDetect's technology in Israel?
- DermaDetect is rolling out its automated skin diagnosis application across the entire Maccabi Health Services network in Israel.
- Has DermaDetect received any grants?
- In December 2022, DermaDetect received a grant of $285,700 from the Israel Innovation Authority.